Conjunctival melanoma: Local-regional control rates, and impact of high-risk histopathologic features

Journal of Cutaneous Pathology

Volumn 38, Issue 1, 2011, Pages 18-24

  Savar, Aaron ^a   Esmaeli, Bita ^a   Ho, Hao ^a   Liu, Suyu ^a   Prieto, Victor G ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Texas Health Science Center at Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CASE REPORT; CONJUNCTIVA TUMOR; EYE SURGERY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CONJUNCTIVAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OPHTHALMOLOGIC SURGICAL PROCEDURES; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 78649659488     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2010.01625.x     Document Type: Article

References (17)

1. Shields CL, Shields JA, Gündüz K, et al., Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000; 118: 1497.
2. Tuomaala S, Eskelin S, Tarkkanen A, Kivelä T., Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in Whites. Invest Ophthalmol Vis Sci 2002; 43: 3399.
3. Clark WH Jr., From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705.
4. Breslow A., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902.
5. Balch CM, Wilkerson JA, Murad TM, et al., The prognostic significance of ulceration of cutaneous melanoma. Cancer. 1980; 45: 3012.
6. Tuomaala S, Kivelä T., Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology 2004; 111: 816.
7. Prieto VG, Clark SH., Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol 2002; 6: 257.
8. Savar A, Ross M, Prieto VG, et al., Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology 2009; 116: 2217.
9. Esmaeli B, Wang B, Deavers M, et al., Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal Plast Reconstr Surg 2000; 16: 250.
10. Balch CM, Buzaid AC, Soong SJ, et al., Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635.
11. Esmaeli B, Youssef A, Naderi A, et al., Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report. Ophthal Plast Reconstr Surg 2003; 19: 96.
12. Kurli M, Finger PT., Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Graefes Arch Clin Exp Ophthalmol 2005; 243: 1108.
13. Hsu A, Frank S, Ballo MT, et al., Post-operative adjuvant external-beam radiation therapy for cancers of the eyelid and conjunctiva. Ophthal Plast Reconstr Surg 2008; 24: 444.
14. Esmaeli B, Eicher S, Popp J, et al., Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg 2001; 17: 436.
15. Ho VH, Ross MI, Prieto VG, Khaleeq A, Kim S, Esmaeli B., Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg 2007; 133: 820.
16. Tuomaala S, Kivelä T., Sentinel lymph node biopsy guidelines for conjunctival melanoma. Melanoma Res 2008; 18: 235.
17. Kirkwood JM, Tarhini AA, Panelli MC, et al., Next generation of immunotherapy for melanoma. J Clin Oncol 2008; 26: 3445.